129 related articles for article (PubMed ID: 9299365)
1. Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the Fe(III)-mitoxantrone complex.
Herman EH; Zhang J; Hasinoff BB; Clark JR; Ferrans VJ
J Mol Cell Cardiol; 1997 Sep; 29(9):2415-30. PubMed ID: 9299365
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187.
Zhang J; Clark JR; Herman EH; Ferrans VJ
J Mol Cell Cardiol; 1996 Sep; 28(9):1931-43. PubMed ID: 8899552
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the chronic toxicity of piroxantrone, losoxantrone and doxorubicin in spontaneously hypertensive rats.
Herman EH; Zhang J; Hasinoff BB; Tran KT; Chadwick DP; Clark JR; Ferrans VJ
Toxicology; 1998 Jun; 128(1):35-52. PubMed ID: 9704904
[TBL] [Abstract][Full Text] [Related]
4. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.
Koutinos G; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
Anticancer Res; 2002; 22(2A):815-20. PubMed ID: 12014656
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats.
Herman EH; el-Hage AN; Ferrans VJ; Ardalan B
Toxicol Appl Pharmacol; 1985 Apr; 78(2):202-14. PubMed ID: 4035676
[TBL] [Abstract][Full Text] [Related]
6. The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity.
Herman EH; Zhang J; Rifai N; Lipshultz SE; Hasinoff BB; Chadwick DP; Knapton A; Chai J; Ferrans VJ
Cancer Chemother Pharmacol; 2001 Oct; 48(4):297-304. PubMed ID: 11710630
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) rats.
Herman EH; el-Hage A; Ferrans VJ
Toxicol Appl Pharmacol; 1988 Jan; 92(1):42-53. PubMed ID: 3124293
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines.
Herman EH; Zhang J; Hasinoff BB; Chadwick DP; Clark JR; Ferrans VJ
Cancer Chemother Pharmacol; 1997; 40(5):400-8. PubMed ID: 9272116
[TBL] [Abstract][Full Text] [Related]
9. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
Herman EH; Zhang J; Chadwick DP; Ferrans VJ
Cancer Chemother Pharmacol; 2000; 45(4):329-34. PubMed ID: 10755322
[TBL] [Abstract][Full Text] [Related]
11. Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: comparative studies against doxorubicin and mitoxantrone.
Cavalletti E; Crippa L; Mainardi P; Oggioni N; Cavagnoli R; Bellini O; Sala F
Invest New Drugs; 2007 Jun; 25(3):187-95. PubMed ID: 17285358
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms responsible for reduced cardiotoxicity of mitoxantrone compared to doxorubicin examined in isolated guinea-pig heart preparations.
Chugun A; Uchide T; Tsurimaki C; Nagasawa H; Sasaki T; Ueno S; Takagishi K; Hara Y; Temma K
J Vet Med Sci; 2008 Mar; 70(3):255-64. PubMed ID: 18388425
[TBL] [Abstract][Full Text] [Related]
13. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.
Kluza J; Marchetti P; Gallego MA; Lancel S; Fournier C; Loyens A; Beauvillain JC; Bailly C
Oncogene; 2004 Sep; 23(42):7018-30. PubMed ID: 15273722
[TBL] [Abstract][Full Text] [Related]
15. Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.
Patel KJ; Trédan O; Tannock IF
Cancer Chemother Pharmacol; 2013 Jul; 72(1):127-38. PubMed ID: 23680920
[TBL] [Abstract][Full Text] [Related]
16. Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.
Herman EH; Lipshultz SE; Rifai N; Zhang J; Papoian T; Yu ZX; Takeda K; Ferrans VJ
Cancer Res; 1998 Jan; 58(2):195-7. PubMed ID: 9443390
[TBL] [Abstract][Full Text] [Related]
17. The novel anthracenedione, pixantrone, lacks redox activity and inhibits doxorubicinol formation in human myocardium: insight to explain the cardiac safety of pixantrone in doxorubicin-treated patients.
Salvatorelli E; Menna P; Paz OG; Chello M; Covino E; Singer JW; Minotti G
J Pharmacol Exp Ther; 2013 Feb; 344(2):467-78. PubMed ID: 23192654
[TBL] [Abstract][Full Text] [Related]
18. Myocardial effects of mitoxantrone and doxorubicin in the mouse and guinea pig.
Perkins WE; Schroeder RL; Carrano RA; Imondi AR
Cancer Treat Rep; 1984 Jun; 68(6):841-7. PubMed ID: 6733698
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in mouse heart by antitumoral drugs: a comparative study of doxorubicin and mitoxantrone.
Lores Arnaiz S; Llesuy S
Toxicology; 1993 Jan; 77(1-2):31-8. PubMed ID: 8442016
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.
Minotti G; Ronchi R; Salvatorelli E; Menna P; Cairo G
Cancer Res; 2001 Dec; 61(23):8422-8. PubMed ID: 11731422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
